Springbok Capital Management »

Travere Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 46k 23.90
2025-06-30 $726k 49k 14.80
2025-03-31 $644k 36k 17.92
2024-06-30 $881k 107k 8.22
2024-03-31 $636k 82k 7.71
2020-12-31 $2.2M 80k 27.26